Signal2026-06-09
ClinicalTrials.gov

[] Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

Part of

Emerging Cancer Biomarker Techniques

Open primary sourceSee the whole picture